CLINICAL_TRIALS
trial_result
· 2017-11-06
Clinical Trial Update: Effects of Dexmedetomidine on Activity in the Subthalamic Nucleus [Phase 4]
Summary
A Phase 4 clinical trial assessed how dexmedetomidine affects activity in the subthalamic nucleus for patients with Parkinson's disease undergoing DBS surgery; …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Wisconsin, Madison | Conditions: Parkinson's Disease, Deep Brain Stimulation Surgery | Phase 4 | Status: COMPLETED | Results posted: 2017-11-06